New Lamps for Old: Atopic Dermatitis and Hemangiomas
Atopic Dermatitis - Future Treatments, and Beta Blocker Therapy for Hemangiomas. Lawrence Schachner MD, Professor and Chair, Department of Dermatology, University of Miami.
Giornate Di Terapia in Dermovenereologia XIV Riunione 1983 -2010. Catania, Monastero dei Benedettini, 30-31 gennaio 2010
Larry Schachner discusses the future treatments for atopic dermatitis and hemangiomas at this extraordinary venue, which brought together most of Italy’s premier dermatologists.
90% of children with acute atopic dermatitis can be assisted with anti staphylococcal therapy including use of topical muperacin, bleach baths, and use of first generation cephalosporins. Over the next 5 years, a host of new preparations will be available for the topical reduction of problems associated with this extraordinarily common and debilitating condition….
Beta blockers have dramatically changed the ways we treat hemangiomas. Life threatening hemagiomatous proliferations are often locally destructive and developmentally disabling. Traditionally, large and rapidly proliferating hemangiomas are a huge challenge when affecting critical areas such as the eyes, nose and mouth on the head and neck. With the advent of interferon, there was great hope that this congenital problem would be ameliorated. But those hopes were dashed when interferon in infants was shown to induce spastic paresis. So now comes the new (or not so new) pharmacologic hope in the guise of propranolol. To date, the results have been pretty spectacular, and with few serious side effects. So let’s hear it for the good guys, like Moyanhan, who came up with Zinc as the answer for acrodermatitis enteropathica, for their unceasing efforts to find safe and effective treatments from among our existing armamentarium of medications, and without having to break the bank.
Popularity: 1% [?]
